Chi Sheng Chemical
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic … Read more
Chi Sheng Chemical (4111) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.013x
Based on the latest financial reports, Chi Sheng Chemical (4111) has a cash flow conversion efficiency ratio of 0.013x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$17.35 Million) by net assets (NT$1.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Chi Sheng Chemical - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Chi Sheng Chemical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Chi Sheng Chemical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chi Sheng Chemical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
I-Tech
ST:ITECH
|
0.072x |
|
QuantaMatrix Inc.
KQ:317690
|
-0.640x |
|
SUN KWANG CO.Ltd
KQ:003100
|
0.038x |
|
Atturra Ltd
AU:ATA
|
0.054x |
|
Qua Granite Hayal Yapi ve Urunleri Sanayi Ticaret AS
IS:QUAGR
|
-0.007x |
|
DK-Lok Corporation
KQ:105740
|
0.012x |
|
South Basic Chemicals JSC
VN:CSV
|
0.042x |
|
Adler Group S.A
PINK:ADPPF
|
0.005x |
Annual Cash Flow Conversion Efficiency for Chi Sheng Chemical (2017–2024)
The table below shows the annual cash flow conversion efficiency of Chi Sheng Chemical from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.27 Billion | NT$213.20 Million | 0.167x | +173.64% |
| 2023-12-31 | NT$1.22 Billion | NT$74.52 Million | 0.061x | -65.23% |
| 2022-12-31 | NT$1.22 Billion | NT$214.86 Million | 0.176x | +38.89% |
| 2021-12-31 | NT$1.10 Billion | NT$139.33 Million | 0.127x | -5.13% |
| 2020-12-31 | NT$1.08 Billion | NT$143.53 Million | 0.133x | -12.25% |
| 2019-12-31 | NT$1.07 Billion | NT$162.96 Million | 0.152x | +39.15% |
| 2018-12-31 | NT$1.05 Billion | NT$114.19 Million | 0.109x | -36.45% |
| 2017-12-31 | NT$1.05 Billion | NT$181.14 Million | 0.172x | -- |